Journal of Studies on Alcohol
Chronic stress exacerbates tau pathology, neurodegeneration, and cognitive performance through a corticotropin-releasing factor receptor-dependent mechanism in a transgenic mouse model of tauopathy
The key considerations include: The stage and severity of liver disease simple steatosis versus NASH, fibrosis, or cirrhosis Overall liver function as assessed through blood tests and clinical evaluation Concurrent chronic alcohol misuse which significantly increases hepatotoxicity risk, particularly in those who are fasting or malnourished Other medications being taken that may affect liver metabolism, including enzyme-inducing drugs (such as carbamazepine, rifampicin, or St John's wort) Adherence to recommended dosing never exceeding maximum daily limits Patients with known fatty liver disease should discuss paracetamol use with their GP or hepatologist, who can assess individual risk factors and provide personalised guidance
Rashid S, Ali N, Nafees S, Ahmad ST, Arjumand W, Hasan SK, Sultana S (2013) Alleviation of doxorubicin-induced nephrotoxicity and hepatotoxicity by chrysin in Wistar rats
Endurance & Fat Metabolism Helps convert fat into energy, supports physical performance, and enhances stamina during workouts
